Sandu Pharmaceuticals Ltd. - Research Center
524703 SANDUPHQ Group (X) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | Sep' 22 | |
|---|---|---|---|---|---|
| Sales | 16.61 | 17.66 | 15.26 | 17.09 | 16.76 |
| Operating profit | 0.83 | 0.36 | 0.48 | 0.82 | 0.86 |
| Interest | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
| Gross profit | 0.90 | 0.33 | 0.51 | 0.83 | 1.01 |
| EPS (Rs) | 0.57 | 0.11 | 0.28 | 0.50 | 0.62 |
Quarterly
results in details
| Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | Sep' 22 | |
|---|---|---|---|---|---|
| Other income | 0.09 | - | 0.04 | 0.03 | 0.17 |
| Stock adjustment | -0.11 | 4.19 | -1.19 | -2.56 | 2.45 |
| Raw material | 2.62 | 1.98 | 3.17 | 3.06 | 2.59 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 2.55 | 2.52 | 3.07 | 2.86 | 2.77 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 10.73 | 8.61 | 9.73 | 12.91 | 8.09 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.13 | 0.12 | 0.13 | 0.13 | 0.13 |
| Taxation | 0.21 | 0.10 | 0.10 | 0.22 | 0.28 |
| Net profit / loss | 0.55 | 0.11 | 0.27 | 0.48 | 0.60 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 9.66 | 9.66 | 9.66 | 9.66 | 9.66 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 4.97 | 2.02 | 3.16 | 4.80 | 5.14 |
| GPM (%) | 5.38 | 1.89 | 3.34 | 4.84 | 5.95 |
| NPM (%) | 3.30 | 0.62 | 1.79 | 2.82 | 3.54 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis